Headline
The latest stories from AHA Today.
A new AHA resource shares ways hospitals and health systems are caring for mothers and babies during the COVID-19 crisis.
The FDA authorized the emergency use of Fresenius Propoven 2% Emulsion, which the agency says "may be effective to maintain sedation via continuous infusion in patients greater than 16 years old with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting."
The Centers for Medicare & Medicaid Services recently provided hospitals with new Medicare blanket waivers to address the COVID-19 public health emergency.
The federal government continues to learn lessons about distributing COVID-19 therapeutics, such as remdesivir, Food and Drug Administration Commissioner Stephen Hahn, M.D., said at a Senate Health, Education, Labor and Pensions Committee hearing.
House Democrats unveiled the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act — a $3 trillion COVID-19 relief package.
The Centers for Medicare & Medicaid Services issued a final rule that implements the standards governing health insurance issuers and the Health Insurance Marketplaces (or “exchanges”) for 2021.
As we mark Mental Health Awareness Month during the COVID-19 pandemic, it’s important to remember that around 45% of U.S. hospitals and health systems do not offer specialized behavioral services.
The Centers for Disease Control and Prevention launched the COVID-19 Data Tracker, a website showing data on U.S. laboratory testing and cases reported to CDC from state health departments and territorial jurisdictions.
The COVID-19 pandemic could increase “deaths of despair” from alcohol, drug misuse and suicide by between 27,644 and 154,037 over the decade, depending how quickly the economy recovers.
The Food and Drug Administration expanded the list of drugs covered under newly flexible compounding policies to include two that may be in short supply because of the COVID-19 pandemic: morphine sulfate and epinephrine.